ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
rdf:type |
rdfs:Resource |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
rdf:type |
owl:Thing |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
rdf:type |
ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
rdf:type |
tido:Hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
rdf:type |
tido:PieceOfInformation |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
prov:wasAttributedTo |
ripekg:human-reviewer/RV012 |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA44B073B6366CEDA7 |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA44B073B6366CEDA7 |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
ripe:rationale |
Checked the journal page and paper and did not find any notices |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
ripe:resultOutcome |
no |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction? |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status |
ripekg:publication-details/RIPEA44B073B6366CEDA7Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by <scp>CPAP</scp>: Randomised phase 3 study |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA44B073B6366CEDA7-human-1-1 |